銘普光磁(002902.SZ):預計半年度虧損6500萬元–8500萬元
格隆匯7月10日丨銘普光磁(002902.SZ)公佈,預計半年度虧損6,500萬元–8,500萬元,扣非虧損7,300萬元–9,300萬元。1、報吿期內受市場環境變化,公司部分訂單階段性減少,行業競爭不斷加劇,新引入的產品尚未形成規模貢獻,導致公司營業收入有所減少,歸屬於上市公司股東的淨利潤同向下降。2、公司目前在積極緊張的佈局光通信之數通光模塊業務,在研發與產能方面提升了投資速度,但因為公司在該領域的影響力較弱,疊加數通光模塊本身要求較長的測試周期,與客户接洽後難以即刻獲取大批量訂單形成規模效應,所以在小批量交貨的模式下產品成本偏高,對盈利能力造成了一定影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.